Orthomolecular Sciences
The molecules of life — in the amounts the body actually needs.
What Orthomolecular Medicine Actually Is
Orthomolecular medicine is the practice of providing the body with the exact molecules it requires, in the exact amounts required, for optimal function. It is not “alternative”. It is the application of biochemistry at clinical doses.
The term was coined by two-time Nobel Prize winner Linus Pauling. The clinical foundation was built by Canadian psychiatrist Dr Abram Hoffer. It was carried to the public by Dr Andrew Saul. In Australia it was pioneered and taught by Professor Ian Brighthope.
The Thinkers
Two-time Nobel Prize winner. He defined orthomolecular medicine as the treatment of disease by varying the concentrations of substances normally present in the human body. His work on vitamin C remains one of the most important — and most contested — bodies of research in modern nutritional science.
Canadian psychiatrist and biochemist. In the 1950s he ran the first double-blind trials in psychiatry using high-dose niacin (vitamin B3) for schizophrenia. Many acute patients improved dramatically on 3–9 grams daily. He founded the Journal of Orthomolecular Medicine because mainstream psychiatry largely ignored the results. He treated thousands of patients over five decades.
Editor of the Orthomolecular Medicine News Service. Walked away from conventional training because he believed the future of health lay in nutrition, not drugs. His widely cited analysis of US data showed that deaths from vitamins are vanishingly rare, while properly prescribed pharmaceutical drugs remain a leading cause of death. The contrast is uncomfortable — and largely ignored.
Australian physician, agricultural scientist, and founding president of the Australasian College of Nutritional and Environmental Medicine (ACNEM) for over 25 years. Pioneer of high-dose intravenous vitamin C clinics in Australia. Treated psychiatric disease, chronic fatigue, auto-immune conditions, cancer support and acute viral illness with megadose nutrient therapy. Continues to advocate that nutritional medicine should sit at the centre of medical practice, not the fringe. Dr Brighthope — if you are reading this, the work continues.
Case Studies — When the Right Molecule Changed Everything
These are documented. Look them up. They are not marketing stories.
1. Allan Smith — New Zealand, 2009
Dairy farmer. Swine flu destroyed his lungs. Placed on ECMO life support. After three weeks doctors told the family there was no hope and asked permission to switch the machines off.
The family refused. They demanded high-dose intravenous vitamin C. Against strong resistance the hospital eventually gave 25–100 g per day. Chest X-rays improved within days. He came off ECMO. When vitamin C was stopped he deteriorated; when it was restarted he improved again. He walked out of hospital. Full kidney recovery. Still alive years later.
This is not a miracle. This is orthomolecular medicine.
2. Kelsey Martin — Virginia, USA, 2015
Young woman with life-threatening sepsis and acute lung injury. Placed on ECMO. High-dose intravenous vitamin C was added as part of a clinical protocol. Family reported watching the chest X-rays improve day by day. She recovered and left hospital.
Her case became part of the growing clinical interest in vitamin C for septic lung injury.
3. Hoffer’s Schizophrenia Patients — Canada, 1950s–2000s
Dr Abram Hoffer and Dr Humphry Osmond ran the first double-blind trials of high-dose niacin in psychiatry. Acute schizophrenic patients receiving 3–9 g of niacin (often with vitamin C) showed recovery rates far higher than expected. Hoffer continued this work for the rest of his life. Many patients who had been written off improved dramatically and stayed well on orthomolecular regimens.
4. Norman Cousins — Ankylosing Spondylitis
Author and editor. Diagnosed with a severe, progressive form of ankylosing spondylitis. Conventional outlook was bleak. He used high-dose intravenous vitamin C (building to 25 g) alongside other measures. Sedimentation rate dropped. Pain reduced. Mobility returned. He documented the process in detail. The case remains one of the best-known self-reported recoveries involving megadose ascorbate.
5. Cancer Cases Documented by Cameron, Pauling & Others
Multiple well-documented cases exist of patients with advanced, histologically confirmed cancers who received high-dose intravenous vitamin C as a primary or major intervention and experienced unexpectedly long survival or tumour regression. Three such cases were published in the Canadian Medical Association Journal under National Cancer Institute Best Case Series guidelines. Pathology was independently verified.
6. Australian Intravenous Vitamin C Clinics — Brighthope Era
Professor Ian Brighthope’s clinics in Melbourne were among the first in Australia to use routine high-dose intravenous vitamin C (often 30–60 g, sometimes higher) for acute viral illness, chronic fatigue, immune dysfunction and cancer support. Clinical observation over decades showed rapid resolution of many acute presentations and meaningful improvement in chronic cases when orthomolecular doses were used consistently.
Why This Knowledge Is Still Treated as Fringe
The Journal of Orthomolecular Medicine has published decades of clinical observation. The safety record of vitamins at high dose is excellent. Deaths from vitamins are rare. Deaths from properly prescribed pharmaceuticals are not.
Yet most medical education still treats high-dose nutrient therapy as fringe. The result is hospital wards where patients are fed white bread and cottage pie while their cells starve for the very molecules that could accelerate recovery.
LGJ BioLabs exists to put this body of work back in front of people who are ready to take responsibility for their own biochemistry.
Educational content only. Not medical advice. All products supplied by LGJ BioLabs are for laboratory research purposes only. Not for human or animal use. Not a medicine.
Enquiries: lukejones@lgjbiotech.com